Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-07
1991-05-28
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514947, A61K 3144
Patent
active
050195794
ABSTRACT:
The object of the invention is a pharmaceutically acceptable composition suitable to achieve a systemic therapeutical response due to its antitussis action in warm-blooded animals, characterized in that it contains, per dosage unit: (I) an amount therapeutically efficacious by systemic way due to the antitussis action of salified dextrorphan, and (II) a pharmaceutically non-toxic excipient acceptable for intranasal administering.
REFERENCES:
patent: 4454140 (1984-06-01), Goldberg et al.
Shanker et al.,-Journal of Pharmacology and Experimental Therapeutics: 120, 528, 1957.
Goodman and Gilman-"The Pharmacological Basis of Therapeutics", 6th ed., 1980, pp. 513, 529.
Casadio Silvano
Del Soldato Piero
Prodotti Formeti S.R.L.
Schenkman Leonard
LandOfFree
Pharmaceutical compositions containing dextrorphan for intranasa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing dextrorphan for intranasa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing dextrorphan for intranasa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36242